Mechanistic Exploration of Therapeutic Targets and Treatable Traits to Improve CNS Outcomes in People with HIV
This grant funds research aimed at exploring therapeutic targets and treatable traits to enhance central nervous system outcomes in individuals living with HIV.
About this program
The Mechanistic Exploration of Therapeutic Targets and Treatable Traits grant is designed to support innovative research that investigates the underlying mechanisms of central nervous system (CNS) complications associated with HIV. This grant aims to identify potential therapeutic targets and traits that can be treated to improve the quality of life for people living with HIV. Researchers are encouraged to propose studies that will lead to a better understanding of how HIV affects the CNS and how these effects can be mitigated through targeted interventions. This funding opportunity is open to academic institutions, nonprofit organizations, and other research entities that are engaged in HIV-related research. The goal is to foster collaboration among scientists, clinicians, and community stakeholders to develop effective strategies for addressing CNS issues in HIV patients. By focusing on mechanistic insights and treatable traits, the grant seeks to pave the way for new therapeutic approaches that can significantly improve patient outcomes.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and research entities focused on HIV-related studies.